Valuation Laboratoires Euromedis
Stocks
ALEMG
FR0000075343
Medical Equipment, Supplies & Distribution
|
Market Closed -
Euronext Paris
11:55:00 2026-09-17 EDT
|
5-day change | 1st Jan Change | ||
| 5.100 EUR | 0.00% |
|
0.00% | +30.10% |
Company Valuation: Laboratoires Euromedis
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 37.64 | 31.27 | 14.38 | 15.54 | 12.54 | 11.15 |
| Change | - | -16.9% | -54.01% | 8.08% | -19.35% | -11.06% |
| Enterprise Value (EV) 1 | 39.66 | 14.94 | 0.4192 | 25.56 | 20.57 | 0.5843 |
| Change | - | -62.32% | -97.19% | 5,997% | -19.52% | -97.16% |
| P/E | 1.8x | 16.7x | -2.37x | 1.16x | -2.05x | -84.9x |
| PBR | 1.05x | 0.77x | 0.41x | 0.67x | 0.76x | 0.68x |
| PEG | - | -0.2x | 0x | -0x | 0x | 0.9x |
| Capitalization / Revenue | 0.19x | 0.28x | 0.27x | 0.46x | 0.34x | 0.27x |
| EV / Revenue | 0.21x | 0.13x | 0.01x | 0.75x | 0.57x | 0.01x |
| EV / EBITDA | 1.23x | 2.88x | -0.1x | -5.76x | 33.3x | 1.09x |
| EV / EBIT | 1.28x | 3.57x | -0.08x | -4.6x | 51.9x | 1.86x |
| EV / FCF | 8.88x | 0.88x | 0.58x | - | - | - |
| FCF Yield | 11.3% | 114% | 173% | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 7.609 | 0.63 | -2.029 | 4.602 | -2.148 | -0.0461 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 193.4 | 111.9 | 54.18 | 34.07 | 36.41 | 41.06 |
| EBITDA 1 | 32.14 | 5.196 | -4.013 | -4.435 | 0.6186 | 0.5337 |
| EBIT 1 | 30.99 | 4.182 | -5.135 | -5.557 | 0.3967 | 0.3142 |
| Net income 1 | 22.66 | 2.256 | -5.933 | 13.11 | -6.108 | -0.1318 |
| Net Debt 1 | 2.02 | -16.33 | -13.96 | 10.02 | 8.037 | -10.57 |
| Reference price 2 | 13.700 | 10.500 | 4.810 | 5.320 | 4.400 | 3.920 |
| Nbr of stocks (in thousands) | 2,747 | 2,978 | 2,990 | 2,922 | 2,849 | 2,844 |
| Announcement Date | 6/3/21 | 4/29/22 | 4/28/23 | 5/5/25 | 5/5/25 | 4/30/26 |
1EUR in Million2EUR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 16.8M | ||
| 29x | 4x | 15.48x | 2.51% | 177B | ||
| 19.59x | 3.57x | 12.77x | 3.04% | 118B | ||
| 17.44x | 0.2x | 12.75x | 0.75% | 60.78B | ||
| 35.04x | 3.4x | 11.62x | 2.16% | 49.53B | ||
| 27.4x | 6.74x | 17.36x | 1.46% | 48.29B | ||
| 35.01x | 6.16x | 19.33x | -.--% | 32.96B | ||
| 42.59x | 1.25x | 11.58x | 0.22% | 28.94B | ||
| 42.22x | 7.4x | 26.55x | 0.25% | 25.48B | ||
| 49.45x | 6.68x | 21.46x | 0.43% | 21.77B | ||
| Average | 33.08x | 4.38x | 16.54x | 1.2% | 56.33B | |
| Weighted average by Cap. | 28.61x | 3.93x | 15.19x | 1.86% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALEMG Stock
- Valuation Laboratoires Euromedis
Select your edition
All financial news and data tailored to specific country editions
















